Eton Pharmaceuticals Inc —— 资产负债表 (NASDAQ:ETON) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 26.32 M27.46 M25.03 M31.74 M76.12 M92.11 M 负债总额 10.66 M9.84 M11.95 M16.26 M51.7 M65.96 M 权益总额 15.66 M17.63 M13.08 M15.48 M24.43 M26.15 M 负债及股东权益总额 26.32 M27.46 M25.03 M31.74 M76.12 M92.11 M 总债务 6.63 M5.28 M5.57 M75 K29.99 M30.56 M 净债务 -14.66 M-9.13 M-10.74 M-21.31 M15.06 M4.62 M

新闻

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Dow Jones Futures: Trump's Iran Comments Spark Stock Market Rally; Micron, Nvidia, Palantir, Tesla Are Big Movers

Stock Market Today: Dow Up As These Leisure Plays Cruise Higher; Pharma Stock Clears Entry (Live Coverage)

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates

Eton Pharmaceuticals获得血管瘤药物美国销售权

Eton Pharmaceuticals acquires U.S. rights to hemangioma drug

DESMODA口服溶液获FDA批准用于治疗尿崩症

DESMODA oral solution receives FDA approval for diabetes insipidus